MMP9 and pulmonary arterial hypertension: For example, integrating suPAR with NT-proBNP (to capture both inflammation and hemodynamic stress) or ECM markers (e.g., MMP-9) could improve risk stratification, particularly in inflammatory PH subsets (e.g., systemic sclerosis-associated PAH) [54,55].